Altamira Therapeutics Ltd. (EARS) Financials

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0.07
Day's range
$0.1
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25M-$30M-$30MEarning2017201720182018201920192020202020212021202220222023202340000%40000%30000%30000%20000%20000%10000%10000%0%0%-10000%-10000%-20000%-20000%-30000%-30000%Profit Margin
Profit Margin
Revenue
Earnings

EARS Income statement / Annual

Last year (2023), Altamira Therapeutics Ltd.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2023, Altamira Therapeutics Ltd.'s net income was -$7.27 M. See Altamira Therapeutics Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $305.62 K $63.88 K $174.48 K -$56.00 K $1.27 M $322.00 K -$414.00 K -$67.00 K $0.00
Cost of Revenue $0.00 $1.44 M $2.24 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 -$1.14 M -$2.18 M $174.48 K -$56.00 K $1.27 M $322.00 K -$414.00 K -$67.00 K $3.01 M
Gross Profit Ratio 0 -3.72 -34.07 1 1 1 1 1 1 0
Research and Development Expenses $3.04 M $14.62 M $3.20 M $2.86 M $3.33 M $6.69 M $19.21 M $24.78 M $26.54 M $17.70 M
General & Administrative Expenses $3.09 M $3.52 M $4.90 M $2.60 M $3.93 M $4.27 M $5.15 M $5.41 M $4.34 M $4.49 M
Selling & Marketing Expenses $15.35 K $15.73 K $39.92 K $95.66 K $113.96 K $43.82 K $161.99 K $45.65 K $72.56 K $237.72 K
Selling, General & Administrative Expenses $3.12 M $3.28 M $3.64 M $2.60 M $3.93 M $4.27 M $5.15 M $5.41 M $4.34 M $4.49 M
Other Expenses $0.00 $112.67 K $30.43 K -$175.00 K $0.00 $215.72 K $87.59 K $34.06 K $62.20 K $73.43 K
Operating Expenses $6.54 M $18.01 M $6.87 M $5.28 M $7.26 M $10.95 M $24.36 M $30.22 M $30.88 M $22.19 M
Cost And Expenses $6.54 M $18.01 M $6.87 M $5.46 M $7.26 M $10.95 M $24.36 M $30.22 M $30.88 M $22.19 M
Interest Income $730.20 K $114.27 K $26.99 K $258.00 $17.88 K $0.00 $53.57 K $67.57 K $37.00 K $3.68 K
Interest Expense $0.00 $911.87 K $14.11 K $135.15 K $28.63 K $1.07 M $1.64 M $828.55 K $8.00 K $49.64 K
Depreciation & Amortization $5.92 M $118.89 K $76.36 K $20.04 K $30.82 K $72.71 K $122.78 K $97.60 K $92.78 K $73.98 K
EBITDA -$1.35 M -$17.64 M -$6.72 M -$8.07 M -$7.24 M -$10.95 M -$24.31 M -$30.06 M -$30.84 M -$22.19 M
EBITDA Ratio 0 -57.71 -105.13 -46.23 129.31 -8.65 -75.49 72.6 460.31 0
Operating Income Ratio 0 -58.94 -83.61 -30.28 129.63 -8.65 -75.66 73 460.86 0
Total Other Income/Expenses Net -$1.35 M -$646.00 K -$1.46 M -$2.94 M $433.41 K -$380.00 K -$66.00 K -$570.00 K $1.17 M $4.01 M
Income Before Tax -$7.27 M -$18.66 M -$6.81 M -$8.22 M -$6.83 M -$11.33 M -$24.43 M -$30.79 M -$29.71 M -$18.19 M
Income Before Tax Ratio 0 -61.06 -106.54 -47.12 121.89 -8.95 -75.86 74.38 443.36 0
Income Tax Expense $0.00 -$10.33 K -$117.95 K -$21.28 K -$194.00 K $162.18 K -$17.77 K -$131.00 K -$84.78 K -$892.00 K
Net Income -$7.27 M -$26.53 M -$17.06 M -$8.20 M -$6.63 M -$11.50 M -$24.41 M -$30.66 M -$29.71 M -$18.19 M
Net Income Ratio 0 -86.8 -267.03 -47 118.43 -9.08 -75.81 74.06 443.36 0
EPS -14.81 -582.58 -515.11 -545.41 -455.96 -2892.03 -22322.34 -35728.56 -36790.93 -26267.51
EPS Diluted -14.8 -582.58 -515.11 -545.41 -455.96 -2892.03 -22322.34 -35728.56 -36790.93 -26267.51
Weighted Average Shares Out $491.00 K $45.54 K $33.12 K $15.04 K $14.55 K $3.98 K $1.09 K $858.20 $807.40 $692.30
Weighted Average Shares Out Diluted $491.26 K $45.54 K $33.12 K $15.04 K $14.55 K $3.98 K $1.09 K $858.20 $807.40 $692.30
Link